Authors: Farlow MR, Cummings JL, Olin JT, Xiangyi M
Title: Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer’s Disease
Source: American Journal of Alzheimer's Disease and Other Dementias 2010 25(4): 347-352
Year: 2010
Research Design: Randomised Controlled Trial
Rating Score: 05/10
This rating is confirmed
Eligibility specified - N
Random allocation - Y
Concealed allocation - N
Baseline comparability - N
Blind subjects - Y
Blind therapists - Y
Blind assessors - N
Adequate follow-up - N
Intention-to-treat analysis - Y
Between-group comparisons - Y
Point estimates and variability - N

Copyright release for this abstract has not been obtained.

Access: Paywall